HERMES PHARMA
  • SearchMobile only
  • ContactMobile only
  • Why HERMES PHARMA
    • Full-service provider
      • Project management
      • Research & development
      • Formulation development
      • Analytical services
      • Clinical studies
      • Regulatory services
      • Sourcing
      • Manufacturing
      • Quality management
      • Logistics & order management
    • Quality-first approach
      • Our QbD/PAT-driven processes
      • Specialist manufacturing facilities
    • Sustainability & ESG
      • Our commitment to sustainability
    • History
    • Executive team
  • Dosage forms & drug delivery
    • Swallowing difficulties
    • User-friendly dosage forms
      • Orally disintegrating granules
      • Chewable tablets
      • Effervescent tablets
      • Instant drinks
      • Lozenges
    • Your route to new products
  • Innovation
    center
    • Featured products
      • Magnesium
      • Macrogol
    • Pioneering technologies
      • Flavoring
      • Taste masking technologies
      • Granulation technologies
      • Serialization
    • User-friendly packaging
      • Innovative packaging options
  • News & media center
    • News & media center
    • Memberships
  • Jobs & careers

Contact

EN DE

Your Search

Reset
  • All results
  • Pages
  • Articles in the press
  • Brochures
  • Company news
  • Educational resources
  • News
  • Podcasts
  • Press releases
  • Videos
  • Events
30 Results
  • Press releases

    HERMES PHARMA announces €25 million investment to bolster capacity

    The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturingHERMES PHARMA manufacturing site in Wolfratshausen, GermanyHERMES PHARMA manufacturing site in Wolfsberg, AustriaPullach, Germany, 26 September 2023 – HERMES PHARMA, the leading expert in user-friendly oral dosage forms, has announced …

  • News

    HERMES PHARMA Again Achieves Silver CSR Award from EcoVadis

    EcoVadis has awarded a third silver medal to HERMES PHARMA in recognition of the company’s sustainability commitment.EcoVadis, one of the world’s most respected provider of business sustainability ratings, has awarded a silver medal to HERMES PHARMA again, recognizing our continued commitment to sustainable and responsible …

  • News

    FDA Approves Magnesium Claim for Heart Health, HERMES PHARMA Expands Magnesium Portfolio

    Magnesium is essential for a variety of vital bodily functions. Deficiency of this critical nutrient is implicated in a host of cardiovascular diseases, currently a leading cause of death globally.As the leading expert in the development and manufacture of user-friendly magnesium products, HERMES PHARMA welcomes …

  • Press releases

    HERMES PHARMA Announces Spin-out from HERMES Arzneimittel

    Dr Thomas Hein, Senior Vice President Commercial & Regulatory Affairs, HERMES PHARMADr Andreas Schrepfer, Managing Director, HERMES PHARMAPullach, Germany, 01 July 2021 – HERMES PHARMA, previously a division of HERMES Arzneimittel GmbH, today announces that it has formed a separate legal entity named HERMES PHARMA GmbH. …

  • News

    HERMES PHARMA Adds Another Top Sustainability Award

    EcoVadis has awarded a second silver CSR medal to HERMES PHARMA in recognition of its sustainability commitment.Demonstrating sustainability through environmental, social, and ethical performance is of increasing importance across all industries. It’s something that we take very seriously at HERMES PHARMA – so we are …

  • News

    Swallowing – a Physical and Mechanical Hazard

    In a recent presentation delivered to the CRN’s Delivery Form Safety Task Force, Procter & Gamble’s Dr. Michael J. Kerins discusses the swallowing difficulties often encountered when taking tablets. In the presentation, Kerins notes that tablets are responsible for more supplement-related ER visits than any other dosage form, …

  • Company news, News

    HERMES PHARMA Joins DCAT

    HERMES PHARMA has become a member of The Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit business development organization facilitating knowledge-sharing and relationships among its community of 500+ global corporate members in the pharmaceutical development and manufacturing space. Founded in 1890, DCAT has been providing …

  • Press releases

    HERMES PHARMA Achieves Top Rating for Sustainability Performance from EcoVadis

    Recognition for the company’s commitment and continuous efforts to meet international CSR standardsPULLACH, Germany, November 12, 2019 — HERMES PHARMA, the leading expert in user-friendly oral dosage forms,today announced that the company together with its affiliates was awarded the Silver Medal by the international rating agency, EcoVadis. This …

  • Press releases

    HERMES PHARMA Opens New Era of Delivering Food Supplements at Vitafoods Europe 2019

    The expert in user-friendly dosage forms launches HERMES NutriCaps, a novel and innovative way to deliver food supplementsHERMES NutriCaps are a finalist for the NutraIngredients Awards 2019 in the category “Editors Award for Functional Food Innovation.”HERMES PHARMA will be exhibiting at Vitafoods 2019 in Geneva. …

  • Press releases

    Johannes Burges Family Foundation

    Family Foundation Ensures Future Independence of HERMES PHARMA and Other Companies of the Johannes Burges GroupPullach, Germany, February 12, 2019 — In a forward-looking move, the Johannes Burges Group (JBU) has set the course for the future of its operations, heralding a new chapter in its …

1 2 3
Next Page
HERMES PHARMA

Privacy policy

Cookie settings

Whistleblowing system

Imprint

Terms of use

Terms & conditions

Sitemap

LinkedIn

Youtube

Code of conduct

Contact
Search
LinkedIn